Agreement signedAgreed 26 Sep 2023

Alfasigma S.p.A. /
Intercept Pharmaceuticals, Inc.

Alfasigma S.p.A. agrees to buy Intercept Pharmaceuticals, Inc.

Buy side: Alfasigma S.p.A.
Buy sideAlfasigma S.p.A.
Target: Intercept Pharmaceuticals, Inc.
TargetIntercept Pharmaceuticals, Inc.
Source · 26 Sep 2023
Buy side: Alfasigma S.p.A.
Buy sideAlfasigma S.p.A.
Target: Intercept Pharmaceuticals, Inc.
TargetIntercept Pharmaceuticals, Inc.
01 / BuyerAlfasigma S.p.A.
02 / TargetIntercept Pharmaceuticals, Inc.
01

What happened

Alfasigma S.p.A. agreed to acquire Intercept Pharmaceuticals, Inc. for $19.00 per Share, according to a filing dated Nov. 8, 2023.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Alfasigma S.p.A. agrees to buy Intercept Pharmaceuticals, Inc.

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

  2. Announced

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.